Pulmatrix Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Lexington MA United States (2003)

Organization Overview

First Clinical Trial
2009
NCT00947687
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Pulmatrix Inc.